Back to search

Democritus University of Thrace (DUTH)

Ο ρόλος της αυτοφαγίας και της λυσοσωμικής βιογένεσης στην ανταπόκριση των γλοιοβλαστωμάτων στην ακτινοθεραπεία

Abstract

dc:description

Glioblastoma is the most common cancer of Central Nervous System and one of the most aggressive human tumors. The median survival of patients is 12 months, while most of the patients pass away within 2 years since diagnosis. The standard treatment protocol includes surgical resection followed by radiotherapy and chemotherapy. Temozolomide is the only chemotherapy agent shown to increase the median survival by 2,6 months, when combined with radiation. Unfortunately, despite the increase of successful treatment rates in various types of human cancer, the median survival in glioblastoma remains poor.The recognized feature of glioblastoma to be resistant to apoptotic stimuli led the scientists to study alternative cell death pathways in order to increase the efficacy of existing treatment methods. A variety of cell pathways may play a role not only in the detection of endogenous differences between normal and cancer cells, but also to understanding how the radiotherapy and chemotherapy affect these procedures.During the last decade many research studies focused on a cell death/survival pathway, namely autophagy. Autophagy constitutes a complicated cell pathway, which supports cell survival under stressful conditions, sustaining the energy balance. The term autophagy includes three different mechanism, macroautophagy, microautophagy and chaperon-mediated autophagy although 'autophagy' is commonly used to describe macroautophagy. During macrοautophagy cytoplasmic components are engulfed by vesicles called autophagosomes and degraded after the fusion of autophagosomes with lysosomes, which contain a variety of proteolytic enzymes. This degradation leads to the recycling of cytoplasmic organelles and molecules.Several studies have focused on the effect of autophagy on the radiotherapy and temozolomide activity in cancer cells. These attempts have provided conflicting results, as some studies suggest that inhibition of autophagy sensitizes cancer cells to radiotherapy and chemotherapy, while others found sensitization following enhancement of autophagy. This paradox reflects the complexity of autophagic pathway and may be related to different patterns of autophagic death.In the current study we investigated the autophagic pathway activity in normal brain and glioblastoma and the effect of radiation on this procedure. Moreover, we studied an eventual sensitization of glioblastoma to radiation and chemotherapy (in vitro and in vivo), by interfering the autophagic pathway.Firstly, using Western blot analysis and immunohistochemistry, we exhibited that there are different expression patterns of autophagic and lysosomal markers between normal brain and glioblastoma. The rate of autophagic flux was higher in glioblastoma cells and tissues as specific structures, called Stone-Like Structure, were observed, eventually as a result of intense autophagic flux and lysosomal exhaustion. Of interest, a direct association between SLS and poor prognosis of glioblastoma patients treated with radiotherapy was confirmed. Furthermore, statistical analysis of immunohistochemistry results showed an association between expression of TFEB with autophagic markers, LC3A and LC3B, and HIF1α. The study of association of Cathepsin D with the same markers exhibited similar results. On the other hand, expression levels of oncogene PTEN were associated with expression levels of LC3B, but not LC3A. These findings supports the different biological role of LC3s.We thereafter performed experiments to identify the localization and kinetics of the three LC3 proteins (A, B and C), in glioblastoma cells. The absence of colocalization between LC3A and LC3B, in the cytoplasm and in the nuclei, supports the distinct role of these two types of autophagosomes. Of interest, LC3A resides in the perinuclear area and nuclei, while LC3B, although distributed throughout the cytoplasm, it localizes in the nucleolar region in the nuclei. An additional interesting finding was the way of LC3s enter the nuclei, using importin a/b, while they leave the nuclei using CRM1/exportin pathway. Colocalization between Beclin 1/LC3A suggested that Beclin 1, may show that Beclin 1 is involved in LC3 nuclear/cytoplasm kinetics, though complex formation with LC3s.Different expression pattern of autophagic and lysosomal markers were observed, not only between normal brain and glioblastoma cells, but between the two different glioblastoma cell lines. Except from endogenous differences between two types of glioblastoma cell lines, the expression levels of these markers were different after radiation, as well. In U87MG cell line radiation inhibits the autophagic flux two days after treatment, while enhances the flux in the T98G cell line.The inhibition of autophagic flux in U87MG cell line may be the reason for the increase radiosenstivity this cell line, as DNA damage (assessed with the γΗ2ΑΧ nuclear foci formation assay) did not differ between the two cell lines. By silencing either of MAP1LC3s or TFEB an important radiosensitization was noted in both glioblastoma cell lines. The radiosensitization activity of autophagy suppression was further confirmed by using in vivo experiments. Finally, the silencing of autophagic flux increased the cytotoxic effect of temozolomide, as well.Taking all the aforementioned into consideration, we conclude that the function of the autophagic machinery is associated with cell survival under stressful conditions and with radio- and chemoresistance of glioblastoma. We suggest that autophagy may function as a prognostic factor for glioblastoma patients undergoing radiotherapy. Moreover, we propose that the specific inhibition of autophagic flux may contribute to the development of radio- and chemosensitization policies aiming to improve the devastating survival figures of glioblastoma patients.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mitrakas, Achilleas
  • Μητράκας, Αχιλλέας

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/39214

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mitrakas, Achilleas; Μητράκας, Αχιλλέας. Ο ρόλος της αυτοφαγίας και της λυσοσωμικής βιογένεσης στην ανταπόκριση των γλοιοβλαστωμάτων στην ακτινοθεραπεία. Democritus University of Thrace (DUTH), 2016. http://hdl.handle.net/10442/hedi/39214